Molecular docking, bioactivity, adme, toxicity risks, and quantum mechanical parameters of some 1,2-dihydroquinoline derivatives were calculated theoretically for investigation of its use as a pharmaceutical active ingredient in the treatment of multiple sclerosis (MS)

Fatih Islamoğlu

doi:10.56782/pps.261

Published : 2024-12-30

Vol. 22 No. 4 (2024)

Molecular docking, bioactivity, adme, toxicity risks, and quantum mechanical parameters of some 1,2-dihydroquinoline derivatives were calculated theoretically for investigation of its use as a pharmaceutical active ingredient in the treatment of multiple sclerosis (MS)

Fatih Islamoğlu

DOI: https://doi.org/10.56782/pps.261

Abstract

In this study, some 1,2-dihydroquinoline derivatives, which have not been synthesized before, were designed, and their usability in the treatment of multiple sclerosis (MS) was investigated. Firstly, a docking study was conducted between the designed molecules and the target proteins (3PP4, 6OBD, 7YXA, and 7TD4) that interact with drugs (International Nonproprietary Name (INN): Ocrelizumab, Alemtuzumab, and Siponimod) used in the treatment of MS. ADME (absorption, distribution, metabolism, and excretion) properties (Boiled Egg graph, bioavailability radar, physicochemical properties, lipophilicity, water solubility, pharmacokinetics, drug similarity, and medicinal chemistry) were analyzed. Bioactivity score, drug-likeness score, drug score, toxicity risks (mutagenic, tumorigenic, irritant, reproductive effective, fathead minnow LC₅₀ (96 hours), daphnia magna LC₅₀ (48 hours), oral rat LD₅₀), bioconcentration factor, and density values were calculated. Quantum mechanical parameters include highest occupied molecular orbital energy (E_HOMO), lowest unoccupied molecular orbital energy (E_LUMO), chemical potential (μ), electron affinity (EA), global softness (S), global hardness (η), ionization potential (IP), total energy, dipole moments, and electrophilicity (ω) values were also calculated for all molecules. As a result of the data obtained from all these studies, (7-(diethylamino)-1,2-dihydroquinolin-3-yl)(6-(diethylamino)-2,3-dihydro-1H-indazol-1-yl)methanone was determined to be the most ideal molecule that can be used as a pharmaceutical active ingredient in the treatment of MS. Bond angles, bond lengths, Mulliken atomic charges, and molecular electrostatic potential (MEP) were calculated for this ideal molecule, and the structure of the molecule was explained in a multifaceted way.

Keywords:

1,2-dihydroquinoline derivatives, molecular docking, multiple sclerosis, ADME, quantum mechanical parameters

Similar Articles

Teresa Żołek, Aleksandra Trzeciak, THE MECHANISM OF ACTION OF INDOLE-3-CARBINOL AND 3,3´-DIINDOLYLMETHANE IN CANCER CHEMOPREVENTION , Prospects in Pharmaceutical Sciences: Vol. 15 No. 2 (2017)
Monika Pawłowska, DESIGN AND PROPERTIES ANALYSIS OF MOLECULARLY IMPRINTED POLYMERS. MOLECULAR MODELING METHOD APPLICATION , Prospects in Pharmaceutical Sciences: Vol. 10 No. 2 (2012)
Piotr Bojanowski, Piotr F. J. Lipiński, Paweł Czekała, Dariusz Plewczyński, MULTITARGET DRUGS – A NEW PARADIGM IN DRUG DESIGN , Prospects in Pharmaceutical Sciences: Vol. 11 No. 1 (2013)
Aneta Affek, Maria Niemyjska, Martyna Wełpa, INDAZOLE DERIVATIVES AS ANTICANCER AGENTS , Prospects in Pharmaceutical Sciences: Vol. 15 No. 1 (2017)
Andrzej Patyra, Marcin Kołakowski, Marta Katarzyna Dudek, Anna Karolina Kiss, Isolation of trachelogenin 4-O-β-D-glucoside from the fruits of Carthamus tinctorius L. , Prospects in Pharmaceutical Sciences: Vol. 20 No. 2 (2022)
Mayur Kadam, Nitin L. Jadhao, Jayant M. Gajbhiye, Synthesis of pyrazole and 1,3,4-oxadiazole derivatives of pharmaceutical potential , Prospects in Pharmaceutical Sciences: Vol. 22 No. 3 (2024)
Bartosz Kózka, Anna Kowalkowska, BENZIMIDAZOLE DERIVATES WITH BIOLOGICAL ACTIVITY , Prospects in Pharmaceutical Sciences: Vol. 15 No. 3 (2017)
Paulina Jeleniewicz, Zuzanna Czarnocka, Dawid Grzeszczuk, Kinga Ostrowska, SELECTED ASPECTS OF BIOLOGICAL ACTIVITY OF 5-HYDROXYCOUMARIN DERIVATIVES , Prospects in Pharmaceutical Sciences: Vol. 16 No. 1 (2018)
Agnieszka Lis-Cieplak, ADAMANTANE DERIVATIVES - VARIETY OF BIOLOGICAL ACTIVITIES. A REVIEW OF MEDICATIONS APPROVED IN POLAND AND POTENTIAL DRUGS , Prospects in Pharmaceutical Sciences: Vol. 10 No. 3 (2012)
Agnieszka Sokal, Edyta Pindelska, COCRYSTALS - A NEW DRUG FORM , Prospects in Pharmaceutical Sciences: Vol. 11 No. 5 (2013)

1 2 3 4 5 > >>

You may also start an advanced similarity search for this article.

Details

References

Statistics

Authors

Download files

PDF

Citation rules

Islamoğlu, F. (2024). Molecular docking, bioactivity, adme, toxicity risks, and quantum mechanical parameters of some 1,2-dihydroquinoline derivatives were calculated theoretically for investigation of its use as a pharmaceutical active ingredient in the treatment of multiple sclerosis (MS). Prospects in Pharmaceutical Sciences, 22(4), 168–187. https://doi.org/10.56782/pps.261

Altmetric indicators

Cited by / Share

Licence

This work is licensed under a Creative Commons Attribution 4.0 International License.

References

1. Taghour, M.S.; Elkady, H.; Eldehna, W.M.; El-Deeb, N.M.; Kenawy, A.M.; Elkaeed, E.B.; Alsfouk, A.A; Alesawy, M.S.; Metwaly, A.M.; Eissa, I.H. Design and synthesis of thiazolidine-2,4-diones hybrids with 1,2-dihydroquinolones and 2-oxindoles as potential VEGFR-2 inhibitors: in-vitro anticancer evaluation and in-silico studies. J. Enzyme Inhib. Med. Chem. 2022, 37(1), 1903-1917. https://doi.org/10.1080/14756366. 2022.2085693

2. Alzweiri, M.; Sweidan, K.; Saleh, O.A.; Al-Helo, T. Synthesis and evaluation of new 2-oxo-1,2-dihydroquinoline-3-carboxamides as potent inhibitors against acetylcholinesterase enzyme. Med. Chem. Res. 2022, 31(9), 1448-1460. https://doi.org/10.1007/s00044-022-02922-x

3. Huddar, S.; Park, C.M.; Kim, H.J.; Jang, S.; Lee, S. Discovery of 4-hydroxy-2-oxo-1,2-dihydroquinolines as potential inhibitors of Streptococcus pneumoniae, including drug-resistant strains. Bioorg. Med. Chem. Lett. 2020, 30(9), 127071-127074. https://doi.org/10.1016/j.bmcl.2020.127071

4. Shahin, M.I.; Roy, J.; Hanafi, M.; Wang, D.; Luesakul, U.; Chai, Y.; Muangsin, N.; Lasheen, D.S.; El Ella, D.A.A; Abouzid, K.A.; Neamati, N. Synthesis and biological evaluation of novel 2-oxo-1,2-dihydroquinoline-4-carboxamide derivatives for the treatment of esophageal squamous cell carcinoma. Eur. J. Med. Chem. 2018, 155, 516-530. https://doi.org/10.1016/j.ejmech.2018.05.042

5. Banu, S.; Bollu, R.; Naseema, M.; Gomedhika, P.M.; Nagarapu, L.; Sirisha, K.; Kumar, C.G.; Gundasw, S.K. A novel templates of piperazinyl-1,2-dihydroquinoline-3-carboxylates: Synthesis, anti-microbial evaluation and molecular docking studies. Bioorg. Med. Chem. Lett. 2018, 28(7), 1166-1170. https://doi.org/ 10.1016/j.bmcl.2018.03.007

6. Agwupuye, J.A.; Gber, T.E.; Edet, H.O.; Zeeshan, M.; Batool, S.; Duke, O.E.E.; Adah, P.O.; Odey, J.O.; Egbung, G.E. Molecular modeling, DFT studies and biological evaluation of methyl 2,8-dichloro-1,2-dihydroquinoline-3-carboxylate. Chem. Phys. Impact. 2023, 6, 100146-100157. https://doi.org/10.1016/j.chphi.2022.100146

7. Hayani, S.; Sert, Y.; Filali, Y.; Benhiba, F.; Chahdi, F.O.; Laraqui, F.Z.; Mague, J.T.; Ibrahimi, B.E.; Sebbar, N.K.; Rodi, Y.K.; Essassi, E.M. New alkyl (cyclohexyl) 2-oxo-1-(prop-2-yn-1-yl)-1, 2-dihydroquinoline-4-carboxylates: Synthesis, crystal structure, spectroscopic characterization, hirshfeld surface analysis, molecular docking studies and DFT calculations. J. Mol. Struct. 2021, 1227, 129520-129534. https://doi.org/10.1016/j.molstruc.2020. 129520

8. Baltina, L.A.; Fairushina, A.I.; Baltina, L.A.; Eropkin, M.Y.; Konovalova, N.I.; Petrova, P.A.; Eropkina, E.M. Eropkina, EM (Eropkina, E. M.), Synthesis and antiviral activity of glycyrrhizic-acid conjugates with aromatic amino acids. Chem. Nat. Compd. 2022, 53(6), 1096-1100. https://doi.org/ 10.1007/s10600-017-2209-7

9. Gaber, A.; Alsanie, W.F.; Alhomrani, M.; Alamri, A.S.; El-Deen, I.M.; Refat, M.S. Synthesis of 1-[(Aryl) (3-amino-5-oxopyrazolidin-4-ylidene)methyl ]-2-oxo-1,2-dihydroquinoline-3-carboxylic acid derivatives and their breast anticancer activity. Crystals 2021, 11(5), 571-582. https://doi.org/ 1096-1100.10.3390/ cryst11050571

10. Kryl'skii, E.D.; Kravtsova, S.E.; Popova, T.N.; Matasova, L.V.; Shikhaliev, K.S.; Medvedeva S.M. 6-Hydroxy-2,2,4-trimethyl-1,2-dihydroquinoline demonstrates anti-inflammatory properties and reduces oxidative stress in acetaminophen-induced liver injury in rats. Curr. Issues Mol. Biol. 2023, 45(10), 8321-8336. https://doi.org/10.3390/ cimb45100525

11. Zidan, T.A.; Yehia, A.A. Novel antioxidants based on polymerized 2,2,4-trimethyl-1,2-dihydroquinoline for styrene-butadiene rubber composites. J. Polym. Res. 2024, 31(6), 170-185. https://doi.org/10.1007/ s10965-024-04006-3

12. Gorojankina, T.; Hoch, L.; Faure, H.; Roudaut, H.; Traiffort, E.; Schoenfelder, A.; Girard, N.; Mann, A.; Manetti, F.; Solinas, A.; Petricci, E.; Taddei, M.; Ruat, M. Discovery, Molecular and Pharmacological Characterization of GSA-10, a Novel Small-Molecule Positive Modulator of Smoothened. Mol. Pharmacol. 2013, 83(5), 1020-1029. https://doi.org/10.1124/ mol.112.084590

13. Lee, C.H.; Jin, H.; Lee, J.H.; Cho, H.J.; Kim, J.; Chung, K.C.; Jung, S.; Paik, S.R. Dequalinium-induced protofibril formation of α-synuclein. J. Biol. Chem. 2006, 281(6), 3463-3472. https://doi.org/10.1074/jbc.M505307200.

14. Kim, H.; Kim, B.J.; Koh, S.; Cho, H.J.; Jin, X.; Kim, B.G.; Choi, J.Y. High mobility group box 1 in the central nervous system: regeneration hidden beneath inflammation. Neural Regen. Res. 2025, 20(1), 107-115. https://doi.org/10.4103/NRR.NRR-D-23-01964

15. Xue, Y.; Yin, P.; Chen, H.; Li, G.; Zhong, D. Novel peripheral blood mononuclear cell mRNA signature for IFN-beta therapy responsiveness prediction in multiple sclerosis. Autoimmunity 2024, 57(1), 1-12. https://doi.org/10.1080/08916934.2024.2332340

16. Leussink, V.I.; Jankovic, M.; Growth, M.; Schuh, K.; Sauerbeck, I.S.; Hoffmann, O. Addition of quantitative MRI to the routine clinical care of patients with multiple sclerosis-results from the MAGNON project. Brain Behav. 2024, 14(6), 1-11. https://doi.org/10.1002/brb3.3548

17. Diem, L.; Ovchinnikov, A.; Friedli, C.; Hammer, H.; Kamber, N.; Chan, A.; Salmen, A.; Findling, O.; Hoepner, R. Efficacy and safety of ocrelizumab in patients with relapsing multiple sclerosis: Real-world experience of two Swiss multiple sclerosis centers. Mult. Scler. Relat. Disord. 2024, 86, 1-7. https://doi.org/10.1016/j.msard.2024.105570

18. Hassan, S.S.; Darwish, E.S.S.; Ahmed, G.K.K.; Azmy, S.R.R.; Haridy, N.A.A. Relationship between disability and psychiatric outcome in multiple sclerosis patients and its determinants. Egypt. J. Neurol. Psychiatry Neurosurg. 2023, 59(1), 105-118. https://doi.org/10.1186/s41983-023-00702-x

19. Curran, C.; Vaitaitis, G.; Waid, D.; Volmer, T.; Alverez, E.; Wagner, D.H. Ocrevus reduces TH40 cells, a biomarker of systemic inflammation, in relapsing multiple sclerosis (RMS) and in progressive multiple sclerosis (PMS). J. Neuroimmunol. 2023, 374, 578008-578019. https://doi.org/10.1016/j.jneuroim.2022.578008

20. Rath, L.; Vijiaratnam, N.; Skibina, O. Alemtuzumab (Lemtrada) in multiple sclerosis: lessons from social media in enhancing patient care. Mult. Scler. J. 2016, 22(3), 335-355.

21. Uosef, A.; Vaughn, N.; Chu, X.; Elshawwaf, M.; Abdelshafy, A.A.A.; Elsaid, K.M.K.; Ghobrial, R.M.; Kloc, M. Siponimod (Mayzent) Downregulates RhoA and Cell Surface Expression of the S1P1 and CX3CR1 Receptors in Mouse RAW 264.7 Macrophages. Arch. Immunol. Ther. Exp. 2020, 68(3), 19-26. https://doi.org/10.1007/s00005-020-00584-4

22. Burley, S.K.; Berman, H.M.; Christie, C.; Duarte, J.M.; Feng, Z.; Westbrook, J.; Young, J.; Zardecki, C. RCSB Protein Data Bank: Sustaining a living digital data resource that enables breakthroughs in scientific research and biomedical education. Protein Sci. 2018, 27(1), 316-330. https://doi.org/10.1016/j.bpj.2018. 11.1783

23. Wang, Y.; Lu, J.; Xiao, H.; Ding, L.; He, Y.; Chang, C.; Wang, W. Mechanism of Valeriana Jatamansi Jones for the treatment of spinal cord injury based on network pharmacology and molecular docking. Medicine 2023, 102(50), 1-9. https://doi.org/10.1097/MD. 0000000000036434

24. Ni, X.; Bao, H.; Guo, J.; Li, D.; Wang, L.; Zhang, W.; Sun, G. Discussion on the mechanism of Danggui Sini decoction in treating diabetic foot based on network pharmacology and molecular docking and verification of the curative effect by meta-analysis. Front. Endocrinol. 2024, 15, 1-14. https://doi.org/10.3389/fendo.2024.1347021

25. Loganathan, V.; Akbar, I.; Ahamed, A.; Alodaini, H.A.; Hatamleh, A.A.; Abuthkir, M.H.S.; Gurusamy, R. Synthesis, antimicrobial and cytotoxic activities of tetrazole N-Mannich base derivatives: Investigation of DFT calculation, molecular docking, and Swiss ADME studies. J. Mol. Struct. 2024, 1300, 1-13. https://doi.org/10.1016/j.molstruc.2023. 137239

26. Jarupula, V.; Kumar, E.P.; Bujji, S.; Shivarathri, P.; Neeradi, S.; Morthad, M.; Reddy, K.L. Synthesis of novel hybrids containing 1,2,3-triazole-linked tetrazole moieties, evaluation of anticancer activity and molecular docking studies. Russ. J. Gen. Chem. 2023, 93(4), 849-857. https://doi.org/10.1134/ S1070363223170012

27. Ganjo, A.R.; Adham, A.N.; Al-Bustany, H.A.; Aka, S.T. Phytochemical analysis and evaluation of antibacterial activity of Moringa oleifera extracts against gram-negative bacteria: an in vitro and molecular docking studies. Curr. Issues Pharm. Med. Sci. 2022, 35(4), 198-205. https://doi.org/10.2478/cipms-2022-0035

28. Daina, A.; Michielin, O.; Zoete, V. SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness, and medicinal chemistry friendliness of small molecules. Sci. Rep. 2017, 7(42717), 1-13. https://doi.org/10.1038/srep42717

29. Pirzada, A.S.; Khan, H.; Alam, W.; Darwish, H.W.; Elhenawy, A.A.; Kuznetsov, A.; Daglia, M. Physicochemical properties, pharmacokinetic studies, DFT approach, and antioxidant activity of nitro and chloro indolinone derivatives. Front. Chem. 2024, 12, 1-15. https://doi.org/10.3389/fchem.2024.1360719

30. Yousuf, M. Advances in in-silico based predictive in-vivo profiling of novel potent β-glucuronidase inhibitors. Curr. Cancer Drug Targets 2019, 19(11), 906-918. https://doi.org/10.2174/15680096196661 90320102238

31. Kumar, A.S.; Bhaskara, B.L. Computational and spectral studies of 3,3′-(propane-1,3-diyl) bis(7,8-dimethoxy-1,3,4,5-tetrahydro-2H-benzo[d]azepin-2-one). Heliyon 2019, 5(9), 1-10. https://doi.org/10.1016/j.heliyon.2019.e02420

32. Morak-Mlodawska, B.; Jelen, M.; Martula, E.; Korlacki, R. Study of lipophilicity and adme properties of 1,9-diazaphenothiazines with anticancer action. Int. J. Mol. Sci. 2023, 24(8), 6970-6981.https://doi.org/ 10.3390/ijms24086970

33. Islamoğlu, F.; Hacıfazlıoğlu, E. Investigation of the usability of some triazole derivative compounds as drug active ingredients by adme and molecular docking properties. Mor. J. Chem. 2022, 10(4), 861-880. https://doi.org/10.48317/IMIST.PRSM/morjchem-v10i3.30855

34. Kuchana, M.; Kaparthi, K. Prediction of physicochemical properties, bioactivity, pharmacokinetics, drug-likeness and synthetic accessibility of phenyl and isoxazole azo dyes. Biosci. Biotechnol. Res. Commun. 2021, 14(5), 301-305. https://doi.org/10.21786/bbrc/14.5/53.

35. Al-Warhi, T.; Said, M.A.; El Hassab, M.A.; Aljaeed, N.; Ghabour, H.A.; Almahli, H.; Eldehna, W.M.; Abdel-Aziz, H.A. Unexpected synthesis, single-crystal x-ray structure, anticancer activity, and molecular docking studies of certain 2-((imidazole/benzimidazol-2-yl)thio)- 1-arylethanon es. Crystals 2020, 10(6), 446-464. https://doi. org/10.3390/cryst10060446

36. Yussoff, M.A.M.; Hamid, A.A.A.; Hamid, S.A.; Halim, K.B.A. Computational quest for finding potential ebola vp40 inhibitors: a molecular docking study. Sains Malays. 2020, 49(3), 537-544. https://doi.org/10.17576/jsm-2020-4903-08

37. Prabha, B.; Ezhilarasi, M.R. Synthesis, spectral characterization, in vitro and in silico studies of benzodioxin pyrazoline derivatives. Biointerface Res. Appl. Chem. 2021, 11(2), 9126-9138. https://doi.org/10.33263/BRIAC112.91269138

38. Ahn, S.; Truong, V.N.P.; Kim, B.; Yoo, M.; Lim, Y.; Cho, S.K.; Koh, D. Design, synthesis, and biological evaluation of chalcones for anticancer properties targeting glycogen synthase kinase 3 beta. Appl. Biol. Chem. 2022, 65(17), 1-14. https://doi.org/10. 1186/s13765-022-00686-x

39. Singh, S.; Gupta, A.K.; Chattree, A.; Verma, A. Lead finding from whole plant of curcuma longa with oxidative potential. Int. J. Pharm. Sci. Res. 2013, 4(8), 3142-3146. https://doi.org/10.13040/IJPSR.0975-8232.4(8).3142-46

40. Silva, Y.K.C.; Reyes, C.T.M.; Rivera, G.; Alves, M.A.; Barreiro, E.J.; Moreira, M.S.A.; Lima, L.M. 3-aminothiophene-2-acylhydrazones: non-toxic, analgesic and anti-inflammatory lead-candidates. Molecules 2014, 19(6), 8456-8471. https://doi.org /10.3390/molecules19068456

41. Vaugelade, S.D.; Nicol, E.; Vujovic, S.; Bourcier, S.; Pirnay, S.; Bouchonnet, S. UV-vis degradation of α-tocopherol in a model system and in a cosmetic emulsion-Structural elucidation of photoproducts and toxicological consequences. J. Chromatogr. A. 2017, 1517, 126-133. https://doi.org/10.1016/j.chroma.2017.08.015

42. Sharma, D.; Thakur, A.; Sharma, M.K.; Sharma, R.; Kumar, S.; Sihmar, A.; Dahiya, H.; Jhaa, G.; Kumar, A.; Sharma, A.K.; Om, H. Effective corrosion inhibition of mild steel using novel 1,3,4-oxadiazole--pyridine hybrids: Synthesis, electrochemical, morphological, and computational insights. Environ. Res. 2023, 234(116555), 1-21. https://doi.org/10.1016/j. envres.2023.116555